NuGen Medical Devices Inc continues to navigate challenges and opportunities within the healthcare sector while maintaining a steady stock performance this week.
NuGen Medical Devices Inc (NGMD.V) has seen no change in its stock price this week, holding steady at C$0.01. As the company faces regulatory hurdles and transitions in leadership, investors are closely watching its next steps.
Advertisement
NuGen Medical Devices Inc
NGMD.V
NGMD.V
NuGen Medical Devices Inc
WealthAwesomeMarket cap
$3.41M
52W high
$0.06
52W low
$0.01
1W change
+0.00%
Beta
1.57
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NGMD's historical volatility
30-Day Vol
242.4%
Annualized
90-Day Vol
216.3%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.01
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.01 | C$0.01 – C$0.03 |
| 60 trading days | C$0.01 | C$0.00 – C$0.04 |
| 90 trading days | C$0.01 | C$0.00 – C$0.05 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: With no significant price movement and ongoing developments in R&D and operational transitions, investors should stay informed about the company’s strategic updates and regulatory status.
NuGen Medical Devices Inc holds a market cap of approximately C$3.41 million.
Despite a year-to-date decline of 57.14%, the recent increase in trading volume suggests heightened interest among investors.
Bull case
NuGen has made progress in research and development, particularly with advancements in needle-free injection technology. This innovation could strengthen its market position and drive future growth.
Bear case
The expiration of its Health Canada license presents a significant challenge, potentially limiting sales and affecting investor confidence until the issue is resolved.
Current Stock Performance
Advertisement
NuGen Medical Devices Inc has reported no change in its stock price this week, maintaining a close of C$0.01. Year-to-date, the stock has declined by 57.14%, reflecting ongoing challenges faced by the company. Despite this, the stock saw a notable increase in trading volume, with 260,000 shares exchanged, significantly above the 20-day average volume of 85,189 shares.
Recent Company News
This week, NuGen Medical Devices Inc did not release any major news that would directly impact its stock price. However, several recent headlines indicate ongoing challenges and developments. The company has announced a temporary halt on device sales in Canada due to an expired Health Canada license, with a new application submitted. Additionally, a change in leadership occurred with the resignation of CFO Veronique Laberge and the appointment of Ajay Mishra as her successor.
Technical Picture
From a technical standpoint, NuGen's stock is trading below its 50-day moving average of C$0.02, indicating a bearish trend. The 200-day moving average also stands at C$0.02, further emphasizing the stock's downward trajectory over the long term. The 52-week range for the stock is C$0.01 to C$0.06, with the current price at the very bottom of this range. The stock's beta of 1.57 suggests it is more volatile than the market, which may attract risk-tolerant investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
